Monday, February 24, 2014

Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). ClinicalTrials.gov Identifier: NCT02069509

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Years

Oral-Diadochokinesis Rates across Languages: English and Hebrew Norms

Oral-Diadochokinesis Rates across Languages: English and Hebrew Norms. Michal Icht, Boaz M. Ben-David; Journal of Communication Disorders, Available online 23 February 2014. http://dx.doi.org/10.1016/j.jcomdis.2014.02.002

Oral-Diadochokinesis has been used to evaluate the presence and severity of neurological impairments. Inaccurate, inconsistent or an abnormal oral-DDK performance might indicate disorders of the central nervous system or peripheral sensory motor functions.

Spinocerebellar ataxia, Parkinson’s disease and Friedreich’s ataxia (both presenting orofacial motor impairments,were characterized with reduced Oral-Diadochokinesis scores.